Idorsia Ltd (IDIA, SW; IDRSF) Monday said that Chief Executive Officer or CEO Srishti Gupta and the company's Board have mutually agreed that she will step down from her role and also resign from the Board of Directors.
The Swiss pharmaceutical research company said that the Board has begun the process of identifying a new CEO. In the interim, Jean-Paul Clozel, Chairman of the Board, will assume responsibility for day-to-day operations and serve as interim CEO until a successor is appointed, Idorsia added.
Commenting on the developments, Jean-Paul Clozel, MD, Chairman of Idorsia said, "On behalf of the Board, I want to thank Srishti for the significant contributions she made as both CEO and Board member during an important period in Idorsia's evolution. She brought real commitment to our mission, and we wish her continued success in her future endeavors."
On the Swiss Exchange, IDIA.SW ended Friday's trading down 3.8 percent at 3.4000 Swiss francs.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.